Not applicableStudy completedNCT01138306What this trial is testingBiomarkers in Samples From Young Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Early research (Phase 1)Study completedNCT00889408What this trial is testingDT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or LymphomaWho this might be right forLeukemiaLymphoma Masonic Cancer Center, University of Minnesota 25
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)Looking for participantsNCT05857969What this trial is testingEx Vivo Drug Sensitivity Testing and Multi-Omics ProfilingWho this might be right forRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more Florida International University 65
Large-scale testing (Phase 3)Ended earlyNCT00630565What this trial is testingStem Cell Transplant in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Testing effectiveness (Phase 2)Study completedNCT01020734What this trial is testingDonor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionWho this might be right forLeukemia Asan Medical Center 263
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Large-scale testing (Phase 3)Study completedNCT00002517What this trial is testingCombination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00003875What this trial is testingBusulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+5 more Fred Hutchinson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00002456What this trial is testingGraft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT02676323What this trial is testingPanobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome St. Jude Children's Research Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00014495What this trial is testingChemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Memorial Sloan Kettering Cancer Center 32
Not applicableStudy completedNCT00445744What this trial is testingCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+19 more Fred Hutchinson Cancer Center 52
Large-scale testing (Phase 3)Study completedNCT00005863What this trial is testingCombination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Medical Research Council
Early research (Phase 1)Study completedNCT00002912What this trial is testingCombination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 3